Quest Diagnostics has grown revenue 5.5% a year over three years and 1.8% a year over five, with earnings per share compounding at 9.8%. Revenue growth, 3-year annual rate: +5.5% (Diagnostics & Research median +9.1%). Revenue growth, 5-year rate: +1.8%, growth has picked up over the last three years. Earnings per share, 3-year rate: +9.8%, earnings outgrew revenue: margins or the share count worked for shareholders. Years of annual history on file: 19, FY2007 to FY2025, as filed.

DGXQuest Diagnostics

HealthcareUSD

$245.03

$171.9552 weeks$245.03

Is it growing?

Is DGX growing?

Quest Diagnostics has grown revenue 5.5% a year over three years and 1.8% a year over five, with earnings per share compounding at 9.8%.

+5.5%

Revenue growth, 3-year annual rate · Diagnostics & Research median +9.1% · steady growth, ahead of inflation · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +1.8%
Revenue growth, 5-year rate · +5.5% over three · growth has picked up over the last three years
Earnings per share, 3-year rate: +9.8%
Earnings per share, 3-year rate · revenue +5.5% · earnings outgrew revenue: margins or the share count worked for shareholders
Years of annual history on file: 19
Years of annual history on file · FY2007 to FY2025, as filed